Interní Med. 2009; 11(1): 16-20

Crohn´s disease - classification, diagnosis, therapy and quality of life

MUDr. Libor Gabalec
Interní oddělení - gastroenterologie, Orlickoústecká nemocnice a.s

Etiology and pathogenesis of Crohn´s disease remains not completely understood. It is unquestionable interaction between the environmental

and genetically susceptible individual. New genes are being describe, but the functional consequences of gene mutations

are not known. New classifications of Crohn´s disease are searching interaction between fenotype and genotype of the disease and

serological markers. Capsule endoscopy and enteroscopy improved detection of small intestinal lesions. In medical therapy the early

use of imunosuppresives and biologic therapy have significant effect on quality of life.

Keywords: Key words: Crohn´s disease, inflammatory bowel disease, quality of life.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gabalec L. Crohn´s disease - classification, diagnosis, therapy and quality of life. Interní Med. 2009;11(1):16-20.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15. Go to original source... Go to PubMed...
    2. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753. Go to original source... Go to PubMed...
    3. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68: 627-635. Go to original source...
    4. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-250. Go to original source... Go to PubMed...
    5. Bitter J, Dyrhonová V. Nespecifické střevní záněty v České republice. Čs Gastroenterol Výž 1992; 46: 313-321.
    6. Hájek J, Vyhnálek P, Bok R, Fabian J, Sillinger P. Nespecifické střevní záněty v regionu Pardubice. Čes. Slov. Gastroent. Hepatol, 2005; 59: 199-203.
    7. Mathew CG. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2008; 9: 9-14. Go to original source... Go to PubMed...
    8. Jewell PD. Crohn´s disease. Medicine 2008; 35: 283-289. Go to original source...
    9. Pintér M, Pintérova KM, Drahošova M, Rejchrt S, Douda T, Tachecí I, Kopáčová M, Bures J. Significance of serum antibodies ANCA, ASCA, ABBA in diagnostics of idiopathic intestinal inflammations. Cas Lek Cesk 2007; 146: 863-867. Go to PubMed...
    10. Rejchrt S, Tachecí I, Bureš J. Kapslová endoskopie. In: Špičák J., ed. Novinky v gastroenterologii a hepatologii. Grada Publishing a.s., 2008: 231-259.
    11. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, Barakauskiene A, Villanacci V, Von Herbay A, Warren BF, Gasche C, Tilg H, Schreiber SW, Scholmerich J, Reinisch W. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 (Suppl 1): i1-15. Go to original source... Go to PubMed...
    12. Slanař O, Bortlík M, Buzková H, Donoval R, Pechandová K, Šebesta I, Lukáš M, Perlík F. Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease. Nucleosides Nucleotides Nucleic Acids 2008; 27: 835-838. Go to original source... Go to PubMed...
    13. Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 2007; 13: 1024-1030. Go to original source... Go to PubMed...
    14. Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55 (Suppl 1): i16-35. Go to original source... Go to PubMed...
    15. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804-810. Go to original source...
    16. Gabalec L, Bureš J, Šedová M, Valenta Z. Quality of life in Crohn´s disease. Gut 2007; (Suppl 3).
    17. Lichtenstein GR, Bala M, Han C, DeWoody K, Schaible T. Infliximab improves quality of life in patients with Crohn's disease. Inflamm Bowel Dis 2002; 8: 237-243. Go to original source... Go to PubMed...
    18. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 23: 1097-1104. Go to original source... Go to PubMed...
    19. Colombel JF, Watson AJ, Neurath MF. The 10 remaining mysteries of inflammatory bowel disease. Gut 2008; 57: 429-433. Go to original source... Go to PubMed...
    20. Cummings JR, Keshav S, Travis SP. Medical management of Crohn's disease. BMJ 2008; 336: 1062-1066. Go to original source... Go to PubMed...
    21. Katz JA. Management of inflammatory bowel disease in adults. J Dig Dis 2007; 8: 65-71. Go to original source... Go to PubMed...
    22. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007; 13: 6134-6139. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.